UK to Begin Negotiating Value-Based Pricing Scheme for Brand Drugs Next Month

Drug Industry Daily
Negotiations on the future of the UK’s pricing and reimbursement policies for brand drugs will begin in September, according to a joint statement from the UK’s Department of Health and the Association of the British Pharmaceutical Industry (ABPI).

To View This Article:


Subscribe To Drug Industry Daily